MedTrace Logo

the Evaluation of the Efficacy of TCI66207 on the Skin.

NCT05143034 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-12-07

No results posted yet for this study

Summary

The purpose of this study is to explore the evaluation of the efficacy of TCI66207 deep-sea live-face bacteria on the skin.

Conditions

  • Skin Diseases

Interventions

DIETARY_SUPPLEMENT

TCI66207 Essence

Use it twice a day after washing your face in the morning and evening for a total of 4 weeks.

DIETARY_SUPPLEMENT

Placebo Essence

Use it twice a day after washing your face in the morning and evening for a total of 4 weeks.

Sponsors & Collaborators

  • TCI Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Chia-Hua Liang, Ph.D · Chia Nan University of Pharmacy ＆ Science

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2019-11-30
Completion
2019-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05143034 on ClinicalTrials.gov